Showing results (81-90 of 143) with videos related to

Sort By:
Pageof 15
Molecular and Cellular Endocrinology|August 14, 2001
Identification of two estrogen regulated genes associated with growth regulation of human breast cancerH Ohlsson, N Brünner, L H Engelholm, et al.
Breast Cancer Research and Treatment|April 1, 1997
Prognostic significance of PAI-1 and uPA in cytosolic extracts obtained from node-positive breast cancer patientsJ Grøndahl-Hansen, S G Hilsenbeck, I J Christensen, et al.
Cancer Research|June 1, 1993
High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosisJ Grøndahl-Hansen, I J Christensen, C Rosenquist, et al.
Endocrine-Related Cancer|September 25, 2003
Validation of real-time RT-PCR for analysis of human breast cancer cell lines resistant or sensitive to treatment with antiestrogensP de Cremoux, C Tran-Perennou, B L Brockdorff, et al.
Endocrine-Related Cancer|June 11, 2005
Tissue inhibitor of metalloproteinases-1 in breast cancerS Ø Würtz, A-S Schrohl, N Møller Sørensen, et al.
European Journal of Haematology|April 1, 1997
Leucocyte and platelet-derived bioactive substances in stored blood: effect of prestorage leucocyte filtrationH J Nielsen, F Skov, E Dybkjaer, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|February 10, 2006
Impact of elective resection on plasma TIMP-1 levels in patients with colon cancerJ H Hammer, L Basse, M N Svendsen, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2001
Prognostic importance of the soluble plasminogen activator receptor, suPAR, in plasma from rectal cancer patientsE Fernebro, R R Madsen, M Fernö, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2003
Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survival. a validation studyM Holten-Andersen, I J Christensen, M Nilbert, et al.
Cancer Research|September 1, 1994
Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissueH Pedersen, N Brünner, D Francis, et al.
Pageof 15